Fusion oncoprotein BCR-ABL, generated by chromosome translocation t(9;22)(q34;q11), is a constitutively active tyrosine kinase [68], whose activity leads to oncogenesis of chronical myeloid leukemia (CML). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.